Nombre del producto:4H-Pyrimido[6,1-a]isoquinolin-4-one, 2-chloro-6,7-dihydro-9,10-dimethoxy-

IUPAC Name:2-chloro-9,10-dimethoxy-4H,6H,7H-pyrimido[4,3-a]isoquinolin-4-one

CAS:75535-96-5
Fórmula molecular:C14H13ClN2O3
Pureza:95%+
Número de catálogo:CM629267
Peso molecular:292.72

Unidad de embalaje Stock disponible Precio($) Cantidad
CM629267-1g in stock ǕǕǕ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :75535-96-5
Fórmula molecular:C14H13ClN2O3
Punto de fusión:-
Código de sonrisas:COC1=CC2=C(C=C1OC)C1=CC(Cl)=NC(=O)N1CC2
Densidad:
Número de catálogo:CM629267
Peso molecular:292.72
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Column Infos

Ensifentrine
Verona Pharma's Ensifentrine was accepted for NDA Review by FDA for chronic obstructive pulmonary disease (COPD) maintenance treatment. COPD is used to describe chronic lung diseases, encompassing emphysema, and chronic bronchitis. Phase 3 ENHANCE trials demonstrated Ensifentrine's efficacy and safety, showing significant improvements in lung function, symptom endpoints, and reducing the rate and risk of COPD exacerbations. Ensifentrine offers a novel mechanism of action. It is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4); it is also an activator of the cystic fibrosis transmembrane conductance regulator (CFTR).

Related Products